Eli Lilly has recently informed Clusterbusters that they are continuing to enroll patients with Episodic Cluster Headache and Chronic Cluster Headache into their clinical studies. Additional sites in North America and Europe are now ready to enroll patients.
For up-to-date information regarding currently enrolling study sites please visit www.clinicaltrials.gov and search for NCT02397473 for the episodic cluster headache trial, or search for NCT02438826 for the chronic cluster headache trial.
To pre-screen for these studies please visit www.ClusterTrials.com or dial the toll free number:
| 1-877-CTLILLY (1-877-285-4559) or | 1-317-615-4559 |
If you pre-qualify for the cluster headache study based on the initial questionnaire, your information will be provided to a physician and you will be contacted for further evaluation.
